We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
A patient alert card is being introduced for men taking finasteride to help raise awareness of the risk of psychiatric side effects and sexual dysfunction, including the potential for sexual dysfunction to persist after treatment has stopped. Healthcare professionals are...
Search for information about medicines including patient information leaflets (PILs), details on how the medicine can be used (SmPCs) and scientific reports (PARs).
Information for patients who have been prescribed Paxlovid (nirmatrelvir 150mg and ritonavir 100mg) film-coated tablets COVID-19 antiviral medication.
The MHRA has approved the combined antibiotic cefepime/enmetazobactam (Exblifep 2 g/0.5 g powder for concentrate for solution for infusion)
A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices.
Collection of information and guidance for patients and for healthcare professionals on the reproductive risks of valproate and new safety measures introduced to reduce these risks.
A new pathway supporting innovative approaches to the safe, timely and efficient development of medicines to improve patient access.
Healthcare professionals prescribing montelukast should be alert to the risk of neuropsychiatric reactions in all patients including children and adolescents. Reported neuropsychiatric reactions include sleep disorders, hallucinations, anxiety and depression, as well as changes in behaviour and mood. Healthcare professionals...
Medical advisory panels work with DVLA to provide expert advice, with the aim of improving road safety. See information on their role and current vacancies.
Robust Home Secretary action has driven an almost 80% fall in student dependant applications in the first quarter of 2024 compared to the same period in 2023.
Directory of current ICH Guidelines which have been implemented by the Medicines and Healthcare products Regulatory Agency.
Check the tariff classification for antimicrobial bathing systems.
How the MHRA makes decisions on when a product is a medical device (borderline products), and which risk class should apply to a medical device.
Advice for medical professionals to use when assessing drivers with cardiovascular disorders.
We handle cases relating to intellectual property disputes about: patents registered designs plant varieties If the amount sought (damages) is under £500,000 then the case can also be heard by the Intellectual Property Enterprise Court . If the amount sought...
News and guidance on veterinary medicines issues affected by coronavirus (COVID-19).
Bringing pets into Great Britain: pet passports, Great Britain pet health certificates, microchipping, rabies vaccinations, travelling with assistance dogs.
Information for patients who have been prescribed Lagevrio (molnupiravir), the COVID-19 oral antiviral medication.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.